首页|重症肾衰竭患者的连续性血液净化与间歇性血液透析治疗效果对比

重症肾衰竭患者的连续性血液净化与间歇性血液透析治疗效果对比

扫码查看
目的 分析重症肾衰竭患者采取间歇性血液透析(IHD)与连续性血液净化(CBP)治疗的效果.方法 100例重症肾衰竭患者,随机分为观察组和对照组,每组50例.观察组行CBP治疗,对照组采用IHD治疗.比较两组患者炎症因子[C反应蛋白(CRP)、白介素6(IL-6)]水平、急性生理学及慢性健康状况(APACHE Ⅱ)评分、血尿素氮(BUN)、血肌酐(Scr)、平均动脉压(MAP)、心率(HR)、并发症发生情况、生活质量.结果 治疗后,观察组患者CRP(10.21±1.14)mg/L、IL-6(28.44±3.10)pg/ml均低于对照组的(13.42±2.09)mg/L、(32.52±4.20)pg/ml,差异显著(P<0.05).治疗后,观察组APACHEⅡ评分(14.84±2.65)分、BUN(20.33±4.03)mmol/L、Scr(277.47±41.20)μmol/L、MAP(87.26±6.37)mm Hg(1 mm Hg=0.133 kPa)、HR(115.02±10.76)次/min均优于对照组的(18.69±2.90)分、(28.76±4.30)mmol/L、(378.94±45.64)μmol/L、(70.34±5.92)mm Hg、(130.45±11.87)次/min,差异显著(P<0.05).观察组并发症发生率6.00% 低于对照组的20.00%,差异显著(P<0.05).治疗后,观察组患者日常生活评分(92.73±1.01)分、疲乏评分(92.02±1.31)分、睡眠评分(93.11±1.03)分、精神评分(90.26±1.57)分、食欲评分(92.04±1.33)分均高于对照组的(86.42±2.38)、(84.24±2.08)、(88.92±2.19)、(85.02±2.40)、(86.41±2.58)分,差异显著(P<0.05).结论 对于重症肾衰竭患者来讲,相比于IHD,CBP治疗效果更理想,值得应用.
Comparison of therapeutic effects of continuous blood purification and intermittent hemodialysis in patients with severe renal failure
Objective To analyze the effects of intermittent hemodialysis (IHD) and continuous blood purification (CBP) in patients with severe renal failure. Methods 100 patients with severe renal failure were randomly divided into an observation group and a control group,with 50 cases in each group. The observation group was treated with CBP,and the control group was treated with IHD. Comparison was made on levels of inflammatory factors[C-reactive protein (CRP),interleukin-6 (IL-6)],acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ) scores,blood urea nitrogen (BUN),serum creatinine (Scr),mean arterial pressure (MAP),heart rate (HR),complications and quality of life between the two groups. Results After treatment,the observation group had CRP of (10.21±1.14) mg/L and IL-6 of (28.44±3.10) pg/ml,which were lower than (13.42±2.09) mg/L and (32.52±4.20) pg/ml in the control group,and the difference was significant (P<0.05). After treatment,the observation group had APACHE Ⅱ score of (14.84±2.65) points,BUN of (20.33±4.03) mmol/L,Scr of (277.47±41.20) μmol/L,MAP of (87.26±6.37) mm Hg (1 mm Hg=0.133 kPa),and HR of (115.02±10.76) beats/min,which were significantly higher than (18.69±2.90) min,(28.76±4.30) mmol/L,(378.94±45.64) μmol/L,(70.34±5.92) mm Hg,and (130.45±11.87) beats/min in the control group,and the difference was significant (P<0.05). The incidence of complications of 6.00% in the observation group was lower than 20.00% in the control group,and the difference was significant (P<0.05). After treatment,the daily life score of the observation group was (92.73±1.01) points,the fatigue score was (92.02±1.31) points,the sleep score was (93.11±1.03) points,the mental score was (90.26±1.57) points,and the appetite score was (92.04±1.33) points,which were higher than (86.42±2.38),(84.24±2.08),(88.92±2.19),(85.02±2.40),and (86.41±2.58) points in the control group,and the difference was significant (P<0.05). Conclusion Compared with IHD,CBP is more effective in the treatment of patients with severe renal failure,and it is worth applying.

Intermittent hemodialysisSevere renal failureContinuous blood purificationQuality of lifeComplicationsRenal function

徐飞

展开 >

223400 涟水县人民医院重症医学科

间歇性血液透析 重症肾衰竭 连续性血液净化 生活质量 并发症 肾功能

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(23)